Subscribe To
CYCC / Cyclacel Pharmaceuticals to Participate in March Investor Conferences
CYCC News
By Zacks Investment Research
October 17, 2023
New Strong Buy Stocks for October 17th
MNTX, PGNY, GFF, RKDA and CYCC have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2023. more_horizontal
By GlobeNewsWire
March 7, 2023
Cyclacel Pharmaceuticals to Participate in March Investor Conferences
BERKELEY HEIGHTS, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), more_horizontal
By Seeking Alpha
August 7, 2022
Cyclacel: Trading At Less Than Half Its Cash Value, Near-Term Catalysts, No Obvious Bear Thesis
Cyclacel Pharmaceuticals is an oncology company with two major value drivers in Phase 1/2 trials and overdue catalysts. It trades at an $11 million ma more_horizontal